Lab21 Announces Appointment of Industry Expert Fraser Logue
News Feb 21, 2012
Lab21 Limited has announced the appointment of Fraser Logue as Group Director of Quality, Regulatory Affairs & Operations Excellence based in the UK.
Dr Logue served two decades in divisions of Abbott Laboratories, most recently as Division Vice President World Wide Manufacturing for Abbott Diabetes Care, moving from Division Vice President European Operations.
He previously served as Operations Director for Abbott Diagnostics Division Ireland, Director of Quality & Regulatory and Marketing Manager for Abbott Diagnostics Division in Germany.
Graham Mullis, CEO of Lab21, said: “I am delighted to have someone of Fraser’s experience join Lab21, especially at a time when we expect to see significant organic growth during the next few years. His senior level international management experience and operations capabilities will ensure Lab21 will meet the demands of increasing sales, entering new markets including the US and the launch of new products.”
Dr Logue said: “Lab21 has achieved remarkable progress within the past 4 years, growing five times in size. I am looking forward to working with and contributing to the future success of Lab21.”
Automated Robotic Device Enables Faster Blood TestingNews
Rutgers researchers have created an automated blood drawing and testing device that provides rapid results, potentially improving the workflow in hospitals and other health-related institutions to allow health care practitioners to spend more time treating patients.READ MORE
Genetic Discovery Helps Determine the Difference Between Aggressive & Benign Bone TumorsNews
The first genetic marker for the bone tumor, osteoblastoma, has been discovered. Whole-genome and transcriptome sequencing of human bone tumors revealed that a genetic change that affects the transcription factor, FOS, is a hallmark mutation of osteoblastoma. The results will help clinicians correctly distinguish benign osteoblastoma tumors from aggressive osteosarcoma tumors and direct the correct treatment.READ MORE
Improved Method for Isolating Extracellular RNANews
In a breakthrough that could lead to powerful new ways to diagnose and track a wide range of medical conditions, scientists at The Rockefeller University have devised an improved method for isolating and identifying tiny fragments of RNA in human blood products.READ MORE
Comments | 0 ADD COMMENT
International Conference on Central Nervous System and Therapeutics
Nov 12 - Nov 14, 2018